Skip to main content

Passage BIO, Inc.

For the period ended Jun 30, 2025. Filed Aug 12, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 12, 2025

PASG$3.43-13.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

​​​​
​ · ​ · Page
PART I.​FINANCIAL INFORMATION4
Item 1.​Interim Financial Statements (Unaudited)4
​​Balance Sheets4
​​Statements of Operations and Comprehensive Loss5
​​Statements of Stockholders’ Equity6
​​Statements of Cash Flows8
​​Notes to Unaudited Interim Financial Statements9
Item 2.​Management’s Discussion and Analysis of Financial Condition and Results of Operations27
Item 3.​Quantitative and Qualitative Disclosures About Market Risk41
Item 4.​Controls and Procedures41
PART II.​OTHER INFORMATION42
Item 1.​Legal Proceedings42
Item 1A.​Risk Factors42
Item 2.​Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities95
Item 3.​Defaults Upon Senior Securities95
Item 4.​Mine Safety Disclosures95
Item 5.​Other Information95
Item 6.​Exhibits96
Signatures98
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.